Avidian Wealth Enterprises LLC Purchases Shares of 1,413 Axon Enterprise, Inc $AXON

Avidian Wealth Enterprises LLC purchased a new stake in Axon Enterprise, Inc (NASDAQ:AXON) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,413 shares of the biotechnology company’s stock, valued at approximately $1,014,000.

Several other large investors have also modified their holdings of AXON. Rakuten Investment Management Inc. bought a new stake in Axon Enterprise during the third quarter valued at about $1,417,000. Triasima Portfolio Management inc. lifted its position in shares of Axon Enterprise by 20.3% during the 3rd quarter. Triasima Portfolio Management inc. now owns 9,343 shares of the biotechnology company’s stock worth $6,705,000 after purchasing an additional 1,578 shares during the last quarter. Americana Partners LLC boosted its stake in Axon Enterprise by 30.5% during the 3rd quarter. Americana Partners LLC now owns 436 shares of the biotechnology company’s stock valued at $313,000 after purchasing an additional 102 shares during the period. Root Financial Partners LLC acquired a new stake in Axon Enterprise in the 3rd quarter valued at approximately $34,000. Finally, Turtle Creek Wealth Advisors LLC acquired a new stake in Axon Enterprise in the 3rd quarter valued at approximately $233,000. 79.08% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on AXON shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a report on Monday, December 29th. Wall Street Zen lowered shares of Axon Enterprise from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. TD Cowen reiterated a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, November 5th. Piper Sandler reduced their price target on shares of Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. Finally, Northcoast Research upgraded shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price objective on the stock in a report on Tuesday, January 6th. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $805.71.

Axon Enterprise Stock Down 1.7%

Shares of NASDAQ:AXON opened at $610.25 on Thursday. Axon Enterprise, Inc has a 12 month low of $469.24 and a 12 month high of $885.91. The firm has a market cap of $48.15 billion, a P/E ratio of 193.12, a P/E/G ratio of 19.54 and a beta of 1.41. The company has a quick ratio of 2.89, a current ratio of 3.12 and a debt-to-equity ratio of 0.57. The company’s 50-day moving average price is $573.99 and its two-hundred day moving average price is $678.74.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.46). The company had revenue of $710.64 million for the quarter, compared to the consensus estimate of $704.83 million. Axon Enterprise had a net margin of 10.05% and a return on equity of 4.29%. Axon Enterprise’s revenue for the quarter was up 30.6% compared to the same quarter last year. During the same period last year, the company earned $1.45 earnings per share. As a group, research analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insider Buying and Selling

In other Axon Enterprise news, Director Jeri Williams sold 100 shares of the company’s stock in a transaction that occurred on Thursday, December 4th. The shares were sold at an average price of $550.63, for a total value of $55,063.00. Following the completion of the sale, the director owned 1,316 shares of the company’s stock, valued at approximately $724,629.08. This represents a 7.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Jennifer H. Mak sold 1,134 shares of the stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $600.00, for a total value of $680,400.00. Following the completion of the sale, the chief accounting officer owned 13,740 shares of the company’s stock, valued at $8,244,000. This trade represents a 7.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 60,540 shares of company stock worth $34,684,738 over the last quarter. Insiders own 4.40% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.